J

Jazz Pharmaceuticals

Biopharmaceuticals focused on neuroscience and oncology

Executive Director - Medical Communications

Biology & BiotechConfirmed live in the last 24 hours
Full-time$280k - $420k

About the Job

Requirements

  • An advanced scientific or healthcare degree is required; accepted credentials include PharmD, PhD, MD, MBBS, Nurse Practitioner, PA, or equivalent.
  • A minimum of 15 years of pharmaceutical or biotechnology experience is required.
  • A minimum of 10 years leading Medical Communications, Medical Affairs, Publications, or related functions is required.
  • Demonstrated success leading global organizations, enterprise transformation initiatives, and innovation programs is required.
  • The role requires executive leadership, strategic thinking, enterprise influence, scientific communication expertise, organizational transformation, digital and AI literacy, talent development, business acumen, stakeholder management, financial accountability, change leadership, collaboration, and integrity.

Responsibilities

  • Lead the vision, strategy, and long-term evolution of Medical Communications.
  • Shape enterprise priorities and ensure communication plans align with evidence generation, development, and commercialization objectives.
  • Represent the function in executive governance forums and provide strategic counsel to senior leadership.
  • Oversee publications, congress activity, scientific narrative development, scientific content, medical education materials, omnichannel engagement content, and evidence dissemination.
  • Ensure global consistency, quality, and scientific excellence.
  • Build and maintain standards, processes, and governance.
  • Own the digital and innovation roadmap for Medical Communications.
  • Evaluate emerging technologies, including generative AI, content automation, advanced analytics, intelligent search, modular content development, and omnichannel engagement platforms.
  • Establish governance and responsible-use frameworks and maintain the organization’s industry innovation position.
  • Identify opportunities to improve efficiency, scientific quality, customer experience, and business impact through innovative technologies and operating models.
  • Lead, develop, and inspire a high-performing global team.
  • Create an inclusive culture that supports diversity of thought, continuous learning, innovation, collaboration, accountability, and employee development.
  • Establish succession plans, leadership development pathways, and capabilities required for future growth.
  • Allocate resources effectively across therapeutic areas and strategic priorities.
  • Develop partnerships across R&D, Clinical Development, Regulatory Affairs, HEOR, RWE, Commercial, Corporate Affairs, Compliance, and Patient Advocacy organizations.
  • Drive integrated planning and execution across the product lifecycle.
  • Influence stakeholders at all organizational levels and foster collaboration and shared accountability.
  • Establish and maintain governance frameworks, operating procedures, quality standards, and performance metrics.
  • Drive continuous improvement initiatives to increase agility, quality, compliance, and efficiency.
  • Ensure activities comply with applicable regulations, industry guidance, publication standards, and internal policies.
  • Manage global budgets, vendor partnerships, and resourcing strategies.
  • Ensure investments deliver measurable business value and support strategic objectives.
  • Monitor performance indicators and communicate outcomes to executive leadership.
  • Drive prioritization and resource allocation decisions.

About the Company

Jazz Pharmaceuticals

Biopharmaceuticals focused on neuroscience and oncology

Jazz Pharmaceuticals is a global biopharmaceutical company focused on neuroscience and oncology, developing and selling therapies for diseases with limited options. Its portfolio includes Xyrem/Xywav for narcolepsy, Epidiolex for seizures, Zepzelca for small cell lung cancer, and Vyxeos for AML. The company grows through a mix of in-house R&D and strategic acquisitions (like GW Pharmaceuticals, Celator, Chimerix) to expand its pipeline. Its goal is to broaden approved therapies and reach patients with limited options by building a diversified, specialty-focused portfolio.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Dublin, Ireland
Founded
2003

Recently Posted Jobs

Explore more opportunities at Jazz Pharmaceuticals

See more jobs